Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications

Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications

Cancer is one of the most important health problems and the second leading cause of death worldwide. Despite the advances in oncology, cancer heterogeneity remains challenging to therapeutics. This is because the exosome-mediated crosstalk between cancer and non-cancer cells within the tumor microen...

Full description

Bibliographic Details
Main Authors:	Vitor Rodrigues da Costa, Rodrigo Pinheiro Araldi, Hugo Vigerelli, Fernanda D’Ámelio, Thais Biude Mendes, Vivian Gonzaga, Bruna Policíquio, Gabriel Avelar Colozza-Gama, Cristiane Wenceslau Valverde, Irina Kerkis
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Cells
Subjects:	exosomes cancer tumor microenvironment (TME) immunomodulation epithelial-mesenchymal transition (EMT) mesenchymal-stem cell (MSC)
Online Access:	https://www.mdpi.com/2073-4409/10/10/2617

Similar Items

Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia
by: Vivian Fonseca Gonzaga, et al.
Published: (2022-07-01)

Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology
by: Rodrigo Pinheiro Araldi, et al.
Published: (2023-08-01)

Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells by Hydrogel Encapsulation
by: Hui-Yun Cheng, et al.
Published: (2024-01-01)

Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
by: Andreas Robert Rudolf Weiss, et al.
Published: (2019-06-01)

Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression
by: Wen-Ming Wang, et al.
Published: (2022-01-01)

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
by: Ding-Yu Rao, et al.
Published: (2023-04-01)

Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration
by: Dae Hyun Ha, et al.
Published: (2020-05-01)

Impacts of priming on distinct immunosuppressive mechanisms of mesenchymal stromal cells under translationally relevant conditions
by: Nick Herger, et al.
Published: (2024-03-01)

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
by: Andreas Behren, et al.
Published: (2019-05-01)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
by: Cláudia Martins-Lima, et al.
Published: (2023-01-01)

New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons
by: Hamed Afkhami, et al.
Published: (2023-10-01)

Identifying the Therapeutic Significance of Mesenchymal Stem Cells
by: Vineet Kumar Mishra, et al.
Published: (2020-05-01)

CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
by: Alasdair G. Kay, et al.
Published: (2022-06-01)

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
by: Alasdair G. Kay, et al.
Published: (2022-12-01)

iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress
by: Masafumi Arakawa, et al.
Published: (2023-09-01)

Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine
by: Vivian Capilla-González, et al.
Published: (2022-05-01)

Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer
by: Shi Zhang, et al.
Published: (2022-04-01)

Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study
by: Kathrine Kronberg Jakobsen, et al.
Published: (2023-09-01)

The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
by: David García-Bernal, et al.
Published: (2021-03-01)

Adipose-Derived Mesenchymal Stem Cell (MSC) Immortalization by Modulation of <i>hTERT</i> and <i>TP53</i> Expression Levels
by: Aigul R. Rakhmatullina, et al.
Published: (2023-11-01)

Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
by: Ahmed Lotfy, et al.
Published: (2023-04-01)

Graphene oxide accelerates TGFβ-mediated epithelial-mesenchymal transition and stimulates pro-inflammatory immune response in amniotic epithelial cells
by: Adrian Cerverò-Varona, et al.
Published: (2023-10-01)

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
by: Mai Abdelgawad, et al.
Published: (2021-08-01)

Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies
by: Xue Yang, et al.
Published: (2023-07-01)

3D Culture and Interferon-γ Priming Modulates Characteristics of Mesenchymal Stromal/Stem Cells by Modifying the Expression of Both Intracellular and Exosomal microRNAs
by: Matteo Bulati, et al.
Published: (2023-07-01)

Stem Cell-Derived Exosomes as Therapeutic Approach for Neurodegenerative Disorders: From Biology to Biotechnology
by: Rodrigo Pinheiro Araldi, et al.
Published: (2020-12-01)

Editorial: Cancer cell adhesion, metastasis, and the immune response
by: Claudia Tanja Mierke
Published: (2023-12-01)

Impact of Epithelial–Mesenchymal Transition on the Immune Landscape in Breast Cancer
by: Fatima-Zohra Khadri, et al.
Published: (2021-10-01)

Immunomodulatory effect of mesenchymal stem cells
by: Luciana Cavalheiro Marti, et al.
Published: (2011-06-01)

Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease
by: Mengqin Yuan, et al.
Published: (2022-05-01)

Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis
by: Hussein Baharlooi, et al.
Published: (2022-03-01)

Editorial: Current progress in mesenchymal stem/stromal cell research, volume II
by: Lindolfo da Silva Meirelles, et al.
Published: (2023-03-01)

Human adipose mesenchymal stem cells-derived exosomes are modulators of in vitro stimulated T-Lymphocytes
by: Rebeca eBlázquez, et al.
Published: (2014-11-01)

Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
by: Mengtian Guo, et al.
Published: (2020-09-01)

Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent
by: Matthew T. Shephard, et al.
Published: (2022-11-01)

Editorial: Current Progress in Mesenchymal Stem/Stromal Cell Research
by: Lindolfo da Silva Meirelles, et al.
Published: (2021-02-01)

Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses
by: Janina Burk, et al.
Published: (2023-10-01)

Biohybrid Bovine Bone Matrix for Controlled Release of Mesenchymal Stem/Stromal Cell Lyosecretome: A Device for Bone Regeneration
by: Elia Bari, et al.
Published: (2021-04-01)

Freeze-Dried Secretome (Lyosecretome) from Mesenchymal Stem/Stromal Cells Promotes the Osteoinductive and Osteoconductive Properties of Titanium Cages
by: Elia Bari, et al.
Published: (2021-08-01)

The Significance of Cancer Stem Cells and Epithelial–Mesenchymal Transition in Metastasis and Anti-Cancer Therapy
by: Lili Liang, et al.
Published: (2023-01-01)